| Year |
Citation |
Score |
| 2023 |
Liu Y, Kimpara S, Hoang NM, Daenthanasanmak A, Li Y, Lu L, Ngo VN, Bates P, Song L, Gao X, Bebel S, Chen M, Chen R, Zhang X, Selberg PE, et al. EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B cell lymphoma. Blood. PMID 37738652 DOI: 10.1182/blood.2023020142 |
0.434 |
|
| 2023 |
Chen Z, Zhou K, Xue J, Small A, Xiao G, Nguyen LXT, Zhang Z, Prince E, Weng H, Huang H, Zhao Z, Qing Y, Shen C, Li W, Han L, ... ... Ngo VN, et al. Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia. Science Translational Medicine. 15: eabq8513. PMID 36989375 DOI: 10.1126/scitranslmed.abq8513 |
0.514 |
|
| 2021 |
Sadras T, Martin M, Kume K, Robinson ME, Saravanakumar S, Lenz G, Chen Z, Song JY, Siddiqi T, Oksa L, Knapp AM, Cutler J, Cosgun KN, Klemm L, Ecker V, ... ... Ngo V, et al. Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer. Molecular Cell. PMID 33878293 DOI: 10.1016/j.molcel.2021.03.043 |
0.614 |
|
| 2019 |
Chen R, Herrera AF, Hou J, Chen L, Wu J, Guo Y, Synold TW, Ngo VN, Puverel S, Mei M, Popplewell L, Yi S, Song JY, Tao S, Wu X, et al. Inhibition of MDR1 overcomes resistance to brentuximab vedotin in Hodgkin lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31811017 DOI: 10.1158/1078-0432.Ccr-19-1768 |
0.306 |
|
| 2019 |
Ngo VN, Müschen M. Chemical choreography of germinal center B-cell migration. Cell Research. PMID 31024167 DOI: 10.1038/S41422-019-0170-7 |
0.589 |
|
| 2019 |
Lee J, Kume K, Chen Z, Xiao G, Cosgun KNN, Chen L, Chan LN, Klemm L, Chen CD, Ma N, Chan WC, Forman SJ, Zammarchi F, Van Berkel P, Melnick A, ... Ngo VN, et al. Dynamic Assembly of a Feedback Complex to Regulate Oncogenic B-Cell Receptor-Signaling Blood. 134: 393-393. DOI: 10.1182/Blood-2019-131270 |
0.419 |
|
| 2018 |
Lee J, Kume K, Chen Z, Xiao G, Cosgun KN, Chan LN, Chen C, Pillai R, Chan WC, Forman SJ, Kwak LW, Zammarchi F, Van Berkel P, Weinstock DM, Melnick AM, ... Ngo VN, et al. CD25-Dependent Feedback Control of the B-Cell Receptor and Its Oncogenic Mimics in B-Cell Malignancies Blood. 132: 776-776. DOI: 10.1182/Blood-2018-99-117553 |
0.466 |
|
| 2016 |
Geem D, Ngo V, Harusato A, Chassaing B, Gewirtz AT, Newberry RD, Denning TL. Contribution of Mesenteric Lymph Nodes and GALT to the Intestinal Foxp3+ Regulatory T-Cell Compartment. Cellular and Molecular Gastroenterology and Hepatology. 2: 274-280. PMID 27570813 DOI: 10.1016/J.Jcmgh.2015.12.009 |
0.393 |
|
| 2016 |
Zhang XH, Ngo VN, Sandoval N, Cui Q, Shi Y, Zain JM, Querfeld C, Guo C, Wu X, Rosen ST. Role of p38γ - NFATc4 - IL17A Pathway As a Potential Therapeutic Target in Cutaneous T Cell Lymphoma Blood. 128: 2725-2725. DOI: 10.1182/Blood.V128.22.2725.2725 |
0.437 |
|
| 2014 |
Mohanty S, Tran T, Sandoval N, Mohanty A, Bedell V, Wu J, Warden C, Scuto A, Collins J, Weisenburger DD, Ngo VN. Cyclin D1 Promotes Survival and Chemoresistance By Maintaining ATR and CHEK1 Signaling in TP53-Deficient Mantle Cell Lymphoma Cell Lines Blood. 124: 5197-5197. DOI: 10.1182/blood.V124.21.5197.5197 |
0.326 |
|
| 2013 |
Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover J, Chang BH, Yost A, Ma W, Fleischman AG, Zhou W, Yang Y, Kleppe M, Ahn Y, Tatarek J, Kelliher MA, et al. TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia. Cancer Discovery. 3: 564-77. PMID 23471820 DOI: 10.1158/2159-8290.Cd-12-0504 |
0.34 |
|
| 2013 |
Mohanty S, Mohanty A, Sandoval N, Bedell V, Murata-Collins J, Wu J, Scuto A, Weisenburger DD, Ngo VN. Cyclin D1 Maintains Mantle Cell Lymphoma Through CDK4-Independent Regulation Of DNA Replicative Checkpoints Blood. 122: 2512-2512. DOI: 10.1182/blood.v122.21.2512.2512 |
0.359 |
|
| 2012 |
Kentsis A, Reed C, Rice KL, Sanda T, Rodig SJ, Tholouli E, Christie A, Valk PJ, Delwel R, Ngo V, Kutok JL, Dahlberg SE, Moreau LA, Byers RJ, Christensen JG, et al. Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia. Nature Medicine. 18: 1118-22. PMID 22683780 DOI: 10.1038/Nm.2819 |
0.315 |
|
| 2012 |
Mohanty S, Sandoval N, Warden C, Ngo VN. A Synthetic Lethal RNA Interference Screen Identifies Components of Genotoxic Stress Response As Targets for Anti-CCND1 Therapy in Mantle Cell Lymphoma. Blood. 120: 2430-2430. DOI: 10.1182/blood.v120.21.2430.2430 |
0.312 |
|
| 2012 |
Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover JM, Chang BH, Yost AJ, Weng AP, Ma W, Tatarek J, Fleischman AG, Ahn Y, Yang Y, Zhou W, Neuberg DS, et al. TYK2-STAT1 Pathway Positively Regulates BCL2 Gene Expression in T-Cell Acute Lymphoblastic Leukemia Blood. 120: 1470-1470. DOI: 10.1182/Blood.V120.21.1470.1470 |
0.365 |
|
| 2010 |
Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 463: 88-92. PMID 20054396 DOI: 10.1038/Nature08638 |
0.455 |
|
| 2010 |
Sanda T, Tyner JW, Gutierrez A, Ngo VN, Moriggl R, Ahn Y, Glover JM, Chang BH, Willis SG, Staudt LM, Druker BJ, Look AT. Pathway Dependence on the Tyrosine Kinase TYK2 and Its Mediator STAT1 In T-Cell Acute Lymphoblastic Leukemia Blood. 116: 3155-3155. DOI: 10.1182/Blood.V116.21.3155.3155 |
0.421 |
|
| 2010 |
Ranuncolo SM, Ngo V, Xiao W, Wright G, Staudt LM. Abstract 3898: Octamer Binding Protein-2 (Oct-2): A non-oncogene addiction in germinal center derived lymphomas and a promising therapeutic target Cancer Research. 70: 3898-3898. DOI: 10.1158/1538-7445.Am10-3898 |
0.607 |
|
| 2009 |
Hailfinger S, Lenz G, Ngo V, Posvitz-Fejfar A, Rebeaud F, Guzzardi M, Penas EM, Dierlamm J, Chan WC, Staudt LM, Thome M. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 106: 19946-51. PMID 19897720 DOI: 10.1073/Pnas.0907511106 |
0.498 |
|
| 2009 |
Bidère N, Ngo VN, Lee J, Collins C, Zheng L, Wan F, Davis RE, Lenz G, Anderson DE, Arnoult D, Vazquez A, Sakai K, Zhang J, Meng Z, Veenstra TD, et al. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature. 458: 92-6. PMID 19118383 DOI: 10.1038/Nature07613 |
0.452 |
|
| 2009 |
Ranuncolo SM, Ngo V, Lenz G, Xiao W, Wright G, Staudt LM. OCT2 (Octamer Binding Protein 2): An Essential Role in Germinal Center B Cell Differentiation and the “Achilles Heel” of Derived Lymphomas. Blood. 114: 362-362. DOI: 10.1182/Blood.V114.22.362.362 |
0.577 |
|
| 2008 |
Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, Xiao W, Powell J, Dave S, Yu X, Zhao H, Zeng Y, Chen B, Epstein J, Staudt LM. IRF4 addiction in multiple myeloma. Nature. 454: 226-31. PMID 18568025 DOI: 10.1038/Nature07064 |
0.367 |
|
| 2008 |
Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science (New York, N.Y.). 319: 1676-9. PMID 18323416 DOI: 10.1126/Science.1153629 |
0.416 |
|
| 2008 |
Lam LT, Davis RE, Ngo V, Wright G, Lenz G, Zhao H, Yu X, Dang L, Staudt LM. Abstract LB-239: An rnai sensitization screen identifies compensatory IKKα activation during IKKβ inhibition Cancer Research. 68. DOI: 10.1158/1538-7445.Am2008-Lb-239 |
0.41 |
|
| 2007 |
Lenz G, Davis RE, Ngo VN, Lam LT, George T, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Muller-Hermelink H, Gascoyne RD, Connors JM, Campo E, Jaffe ES, et al. CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma. Blood. 110: 692-692. DOI: 10.1182/Blood.V110.11.692.692 |
0.489 |
|
| 2006 |
Shaffer AL, Wright G, Yang L, Powell J, Ngo V, Lamy L, Lam LT, Davis RE, Staudt LM. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunological Reviews. 210: 67-85. PMID 16623765 DOI: 10.1111/J.0105-2896.2006.00373.X |
0.446 |
|
| 2006 |
Ngo VN, Davis RE, Lamy L, Yu X, Zhao H, Lenz G, Lam LT, Dave S, Yang L, Powell J, Staudt LM. A loss-of-function RNA interference screen for molecular targets in cancer. Nature. 441: 106-10. PMID 16572121 DOI: 10.1038/Nature04687 |
0.576 |
|
| 2004 |
Cupedo T, Lund FE, Ngo VN, Randall TD, Jansen W, Greuter MJ, de Waal-Malefyt R, Kraal G, Cyster JG, Mebius RE. Initiation of cellular organization in lymph nodes is regulated by non-B cell-derived signals and is not dependent on CXC chemokine ligand 13. Journal of Immunology (Baltimore, Md. : 1950). 173: 4889-96. PMID 15470030 DOI: 10.4049/Jimmunol.173.8.4889 |
0.739 |
|
| 2002 |
Cyster JG, Ansel KM, Ngo VN, Hargreaves DC, Lu TT. Traffic patterns of B cells and plasma cells. Advances in Experimental Medicine and Biology. 512: 35-41. PMID 12405185 DOI: 10.1007/978-1-4615-0757-4_5 |
0.829 |
|
| 2002 |
Okada T, Ngo VN, Ekland EH, Förster R, Lipp M, Littman DR, Cyster JG. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. The Journal of Experimental Medicine. 196: 65-75. PMID 12093871 DOI: 10.1084/Jem.20020201 |
0.804 |
|
| 2001 |
Ngo VN, Cornall RJ, Cyster JG. Splenic T zone development is B cell dependent. The Journal of Experimental Medicine. 194: 1649-60. PMID 11733579 DOI: 10.1084/Jem.194.11.1649 |
0.792 |
|
| 2001 |
Ruuls SR, Hoek RM, Ngo VN, McNeil T, Lucian LA, Janatpour MJ, Körner H, Scheerens H, Hessel EM, Cyster JG, McEvoy LM, Sedgwick JD. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity. 15: 533-43. PMID 11672536 DOI: 10.1016/S1074-7613(01)00215-1 |
0.551 |
|
| 2001 |
Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, Suzuki G, Zou YR, Littman DR, Cyster JG. A coordinated change in chemokine responsiveness guides plasma cell movements. The Journal of Experimental Medicine. 194: 45-56. PMID 11435471 DOI: 10.1084/Jem.194.1.45 |
0.696 |
|
| 2000 |
Cyster JG, Ansel KM, Reif K, Ekland EH, Hyman PL, Tang HL, Luther SA, Ngo VN. Follicular stromal cells and lymphocyte homing to follicles. Immunological Reviews. 176: 181-93. PMID 11043777 |
0.786 |
|
| 2000 |
Ansel KM, Ngo VN, Hyman PL, Luther SA, Förster R, Sedgwick JD, Browning JL, Lipp M, Cyster JG. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 406: 309-14. PMID 10917533 DOI: 10.1038/35018581 |
0.825 |
|
| 1999 |
Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. The Journal of Experimental Medicine. 190: 1123-34. PMID 10523610 DOI: 10.1084/jem.190.8.1123 |
0.774 |
|
| 1999 |
Cyster JG, Ngo VN, Ekland EH, Gunn MD, Sedgwick JD, Ansel KM. Chemokines and B-cell homing to follicles. Current Topics in Microbiology and Immunology. 246: 87-92; discussion 93. PMID 10396043 DOI: 10.1007/978-3-642-60162-0_11 |
0.773 |
|
| 1999 |
Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, Browning JL, Sedgwick JD, Cyster JG. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. The Journal of Experimental Medicine. 189: 403-12. PMID 9892622 DOI: 10.1084/Jem.189.2.403 |
0.71 |
|
| 1998 |
Ngo VN, Tang HL, Cyster JG. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. The Journal of Experimental Medicine. 188: 181-91. PMID 9653094 DOI: 10.1084/Jem.188.1.181 |
0.778 |
|
| 1998 |
Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature. 391: 799-803. PMID 9486651 DOI: 10.1038/35876 |
0.786 |
|
| Show low-probability matches. |